DiscoverIn the Thick of ItUnderstanding NSVT: Risk Assessment and ICD Decisions in HCM
Understanding NSVT: Risk Assessment and ICD Decisions in HCM

Understanding NSVT: Risk Assessment and ICD Decisions in HCM

Update: 2025-02-14
Share

Description

How do we determine which hypertrophic cardiomyopathy patients are at the highest risk for sudden cardiac death? In this episode of In the Thick of It, Dr. Steve Ommen and Dr. Mark Link take a deep dive into the role of non-sustained ventricular tachycardia (NSVT) in risk assessment and ICD decision-making. They discuss how age, VT duration, and other clinical factors influence risk stratification, as well as the evolving guidelines on ICD placement. The conversation also covers the latest advancements in device technology and the nuances of selecting the right ICD for each patient. Don’t miss this essential discussion on refining risk assessment and improving outcomes in HCM care.

Season 2 of In the Thick of It is brought to you by the HCM Society, is supported by sponsorship from Cytokinetics, and is produced by Earfluence.

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Understanding NSVT: Risk Assessment and ICD Decisions in HCM

Understanding NSVT: Risk Assessment and ICD Decisions in HCM

Hypertrophic Cardiomyopathy Medical Society